Shield Pharmaceuticals Corp
Shield Pharmaceuticals Corp., headquartered in the United States, is a prominent player in the pharmaceutical industry, specialising in the development and distribution of innovative healthcare solutions. Founded in 2005, the company has achieved significant milestones, including the launch of several core products that address critical medical needs.
With a focus on therapeutic areas such as oncology and infectious diseases, Shield Pharmaceuticals distinguishes itself through its commitment to research and development, ensuring that its offerings are both effective and safe. The company has established a strong market position, recognised for its high-quality formulations and patient-centric approach. As it continues to expand its operational reach, Shield Pharmaceuticals remains dedicated to improving health outcomes globally.
-9 vs industry average
Shield Pharmaceuticals Corp’s score of 13 is lower than 33% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Part of the Sustainability team at Shield Pharmaceuticals Corp?
- Control how your company's emission story is told
- Respond to customers efficiently
- See who's viewing your profile
Industry Intensity
Health Services has typical carbon intensity
Industry performance
The Health Services industry has increased its overall emissions by 7% since 2019
Reported emissions
No reported emissions data is available for Shield Pharmaceuticals Corp yet.
Shield Pharmaceuticals Corp's reported carbon emissions
Shield Pharmaceuticals Corp, headquartered in the US, currently does not report any carbon emissions data, as indicated by the absence of specific figures in kg CO2e. Additionally, there are no documented reduction targets or climate pledges associated with the company. This lack of data suggests that Shield Pharmaceuticals may not have established formal commitments to reduce its carbon footprint or engage in industry-standard climate initiatives.
In the context of the pharmaceutical industry, many companies are increasingly adopting science-based targets and sustainability initiatives to address climate change. However, without specific emissions data or commitments, it is unclear how Shield Pharmaceuticals aligns with these industry trends. As the company moves forward, establishing measurable climate goals and reporting emissions could enhance its sustainability profile and contribute to broader environmental efforts.
Unlock detailed emission data
Access structured emission data, company specific factors and auditable source documents
Shield Pharmaceuticals Corp’s Climate Goals (2030 & 2050)
No climate goals have been disclosed for Shield Pharmaceuticals Corp yet.
Scope 3 top emissions categories
No scope 3 category breakdown has been disclosed yet.
Emissions comparison with industry peers
View similar organisations
Shield Pharmaceuticals Corp
Usage policy
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Where does DitchCarbondata come from?
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn moreCurious to see your top suppliers emissions?
Book a demo for a pilot project